Related Experiment Video
Updated: Aug 30, 2025

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
Published on: December 20, 2024
Glucocorticoid Receptor Function and Cognitive Performance in Women With HIV
Leah H Rubin1, Mandakh Bekhbat, Susie Turkson
1From the Department of Neurology and Psychiatry (Rubin), Johns Hopkins University School of Medicine; Department of Epidemiology (Rubin, Springer, Gange), Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Emory University School of Medicine (Bekhbat); Department of Biostatistics and Bioinformatics, Rollins School of Public Health (Mehta), Emory University, Atlanta, Georgia; Department of Psychiatry, Psychology and Obstetrics & Gynecology (Maki), University of Illinois at Chicago, Chicago, Illinois; Departments of Medicine, Epidemiology & Population Health, and Obstetrics & Gynecology and Women's Health (Anastos), Albert Einstein College of Medicine, Bronx; Department of Neurology (Gustafson), SUNY-Downstate Health Sciences University, Brooklyn, New York; Department of Medicine (Spence), Georgetown University, Washington, DC; Institute for Health Promotion and Disease Prevention Research (Milam), University of Southern California, Los Angeles; Weill Institute for Neurosciences, Department of Neurology, and Division of Infectious Diseases (Chow), University of California, San Francisco, San Francisco, California; The Core Center, Bureau of Health Services of Cook County (Weber), Chicago, Illinois; and Department of Anatomy and Neurobiology, School of Medicine (Neigh), Virginia Commonwealth University, Richmond, Virginia.
Objective:
Alterations in glucocorticoid receptor (GCR) function may be a risk factor for cognitive complications among older people with human immunodeficiency virus (HIV). We evaluated whether HIV serostatus and age modify the GCR function-cognition association among women.
Methods:
Eighty women with HIV ( n = 40, <40 years of age [younger]; n = 40, >50 years of age [older]) and 80 HIV-uninfected women ( n = 40 older, n = 40 younger) enrolled in the Women's Interagency HIV Study completed a comprehensive neuropsychological test battery. Peripheral blood mononuclear cells collected concurrent with neuropsychological testing were assessed for GCR function. Multivariable linear regression analyses were conducted to examine whether a) HIV serostatus and age were associated with GCR function, and b) GCR function-cognition associations are moderated by HIV serostatus and age adjusting for relevant covariates.
Results:
Among older women, higher baseline FKBP5 expression level was associated with lower attention/working memory performance among women with HIV ( B = 6.4, standard error = 1.7, p = .0003) but not in women without HIV infection ( B = -1.7, standard error = 1.9, p = .37). There were no significant HIV serostatus by age interactions on dexamethasone (DEX)-stimulated expression of the genes regulated by the GCR or lipopolysaccharide-stimulated tumor necrosis factor α levels (with or without DEX stimulation; p values > .13). HIV serostatus was associated with GC target genes PER1 ( p = .006) and DUSP1 ( p = .02), but not TSC22D3 ( p = .32), after DEX stimulation.
Conclusions:
Collectively, these data suggest that HIV serostatus and age may modify the influence of the GCR, such that the receptor is likely engaged to a similar extent, but the downstream influence of the receptor is altered, potentially through epigenetic modification of target genes.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Hypothalamic-Pituitary Axis
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

